May 15, 2018
Takeda Pharmaceutical notched up double-digit profit growth in the year ended in March on group revenues of 1.77 trillion yen, which rose 2.2% over the previous year as bullish Entyvio (vedolizumab) sales more than offset a decline stemming from the...read more